Ximelagatran
CAS: 192939-46-1
Ref. TM-T17265
1mg | 66.00 € | ||
5mg | 120.00 € | ||
10mg | 201.00 € | ||
25mg | 465.00 € | ||
50mg | 519.00 € | ||
100mg | 740.00 € | ||
200mg | 1,040.00 € | ||
1ml*10 (DMSO) | 137.00 € |
Product Information
- EXANTA, H 376-95, H37695, H 376/95, H-37695, H 37695
- Exanta/Ximelegatran
- Glycine, N-[(1R)-1-cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethyl]-, ethyl ester
- H 376/95
- N-[(1R)-1-Cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethyl]glycine Ethyl Ester
- Ximelegatran
- ethyl N-{(1R)-1-cyclohexyl-2-[(2S)-2-{[4-(N'-hydroxycarbamimidoyl)benzyl]carbamoyl}azetidin-1-yl]-2-oxoethyl}glycinate
Ximelagatran (H 376-95), a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.
Chemical properties
Technical inquiry about: TM-T17265 Ximelagatran
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.